Pro-Dex Past Earnings Performance

Past criteria checks 1/6

Pro-Dex's earnings have been declining at an average annual rate of -5%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 11.7% per year. Pro-Dex's return on equity is 16.9%, and it has net margins of 9.2%.

Key information

-5.0%

Earnings growth rate

-2.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate11.7%
Return on equity16.9%
Net Margin9.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Pro-Dex makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:PDXN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2457553
30 Jun 2454253
31 Mar 2449252
31 Dec 2348352
30 Sep 2347552
30 Jun 2346752
31 Mar 2348852
31 Dec 2244752
30 Sep 2243562
30 Jun 2242562
31 Mar 2239353
31 Dec 2141563
30 Sep 2139664
30 Jun 2138654
31 Mar 2140853
31 Dec 2036753
30 Sep 2036642
30 Jun 2035642
31 Mar 2031432
31 Dec 1929432
30 Sep 1927432
30 Jun 1927432
31 Mar 1926332
31 Dec 1825332
30 Sep 1824232
30 Jun 1822232
31 Mar 1822232
31 Dec 1723232
30 Sep 1722531
30 Jun 1722531
31 Mar 1721431
31 Dec 1620431
30 Sep 1620231
30 Jun 1619131
31 Mar 1618131
31 Dec 1517031
30 Sep 1515032
30 Jun 1513032
31 Mar 1513032
31 Dec 1411-122
30 Sep 1411-121
30 Jun 1411-121
31 Mar 1410-132
31 Dec 1311-232

Quality Earnings: PDXN has high quality earnings.

Growing Profit Margin: PDXN's current net profit margins (9.2%) are lower than last year (11.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PDXN's earnings have declined by 5% per year over the past 5 years.

Accelerating Growth: PDXN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: PDXN had negative earnings growth (-0.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (10.1%).


Return on Equity

High ROE: PDXN's Return on Equity (16.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 06:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pro-Dex, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC